Vonoprazan Placebo

DRUG2 trials

Sponsors

Takeda

Conditions

Erosive Esophagitis

Phase 3

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis

CompletedNCT02388737

TakedaErosive Esophagitis

Start: 2015-04-01End: 2018-12-31Updated: 2020-02-21

Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis

CompletedNCT02388724

TakedaErosive Esophagitis

Start: 2015-03-24End: 2017-07-27Updated: 2019-06-03

Related Papers

Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial

Chinese Medical Journal2024-03-2910 citations

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

Gut2019-08-13139 citations